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RESEARCH ARTICLE
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The International Study of Asthma and Allergies in Children (ISAAC) Wheezing Module is
commonly used to characterize pediatric asthma in epidemiological studies, including nearly
all airway cohorts participating in the Environmental Influences on Child Health Outcomes
(ECHO) consortium. However, there is no consensus model for operationalizing wheezing
severity with this instrument in explanatory research studies. Severity is typically measured
using coarsely-defined categorical variables, reducing power and potentially underestimat-
ing etiological associations. More precise measurement approaches could improve testing
of etiological theories of wheezing illness.
Methods
We evaluated a continuous latent variable model of pediatric wheezing severity based on
four ISAAC Wheezing Module items. Analyses included subgroups of children from three
independent cohorts whose parents reported past wheezing: infants ages 0–2 in the
INSPIRE birth cohort study (Cohort 1; n = 657), 6-7-year-old North American children from
Phase One of the ISAAC study (Cohort 2; n = 2,765), and 5-6-year-old children in the
EHAAS birth cohort study (Cohort 3; n = 102). Models were estimated using structural equa-
tion modeling.
Results
In all cohorts, covariance patterns implied by the latent variable model were consistent with
the observed data, as indicated by non-significant χ2 goodness of fit tests (no evidence of
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model misspecification). Cohort 1 analyses showed that the latent factor structure was sta-
ble across time points and child sexes. In both cohorts 1 and 3, the latent wheezing severity
variable was prospectively associated with wheeze-related clinical outcomes, including phy-
sician asthma diagnosis, acute corticosteroid use, and wheeze-related outpatient medical
visits when adjusting for confounders
Conclusion
We developed an easily applicable continuous latent variable model of pediatric wheezing
severity based on items from the well-validated ISAAC Wheezing Module. This model pro-
spectively associates with asthma morbidity, as demonstrated in two ECHO birth cohort
studies, and provides a more statistically powerful method of testing etiologic hypotheses of
childhood wheezing illness and asthma.
Introduction
Background
Asthma is among the most common and costly diseases affecting childhood [1,2]. Large epidemi-
ological studies aimed at advancing understanding of the development and sequelae of asthma
often rely on brief questionnaires that can be broadly implemented to characterize symptom
severity [3,4]. Investigators for the International Study of Asthma and Allergies in Children
(ISAAC) [3] developed and validated a research questionnaire assessing wheezing symptoms [3,5]
that has since been used worldwide to assess the prevalence and etiology of asthma [4,6–10]. The
ISAAC Wheezing Module (ISAAC-WM) includes eight items, four specifically focused on wheez-
ing, either parent-reported for younger children or self-reported by older children [3]. The ques-
tionnaire and manual are available at http://isaac.auckland.ac.nz/story/methods/methods.php.
There is no consensus method for operationalizing wheezing severity using the ISAAC-WM.
Respondents endorsing past-year wheezing complete three items assessing the frequency of
wheezing episodes and negative sequelae in the past 12 months. Additionally, all respondents
report on whether or not their child experienced exercise-induced wheezing [3]. Researchers
typically stratify children into discrete severity groups based on frequency of wheezing episodes
(item 3), wheeze-related sleep disturbance (item 4), wheeze-related speech disturbance (item 5)
[7], exercise-induced wheezing (item 7), or a combination of these items [11].
Discrete severity variables are suboptimal in explanatory research as they artificially reduce
variability, grouping individuals with truly differing severity levels into the same data bins
[12]. This reduces power, likely resulting in underestimates of etiological associations and sub-
optimal theory testing [12,13]. A number of research groups have used exploratory techniques,
like principal components [14,15] or latent factor approaches [16,17], to develop continuous
asthma severity measures [18]. To our knowledge, however, no studies have tested the plausi-
bility of these models using confirmatory analytic techniques. Additionally, we know of no
studies, either exploratory or confirmatory, evaluating the ability of the ISAAC-WM to capture
pediatric wheezing severity on a continuous scale for research purposes.
Purpose
There are a number of large epidemiological studies evaluating pediatric wheezing illness
using the ISAAC-WM [4,8,19,20], including nearly all airway cohorts participating in the
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Environmental Influences on Child Health Outcomes (ECHO) initiative [21]. ECHO is an
NIH-funded consortium of previously established birth cohorts aimed at understanding the
modifiable environmental etiologies of four major diseases, including asthma [21]. These stud-
ies contain rich data (e.g., early life exposures and wheeze-related clinical outcomes), providing
opportunities to test etiological models of wheezing illness development and outcomes. To
conduct strong tests of theory, however, it is critical to measure wheezing severity with optimal
precision. The purpose of this study is to demonstrate how studies using the ISAAC-WM can
use structural equation modeling (SEM) to estimate wheezing severity as a continuous latent
variable. Using a continuous latent variable approach, rather than discrete severity variables,
may lead to more precise measurement and stronger tests of etiological theory [22] in studies
using the ISAAC-WM. This, in turn, could lead to improved understanding of pediatric
wheezing illness and strengthen prevention and early intervention efforts.
SEM is a flexible multivariate statistical approach that supports precise specification of
theoretical models and estimation of latent variables representing constructs that we cannot
measure directly [22–25]. Latent factors capture shared variance among multiple measured
variables (factor indicators) believed to have a common underlying cause [25,26]. In this study,
we conceptualize wheezing illness as a latent (unobserved) variable that has measurable conse-
quences (e.g., wheezing attacks, disturbed sleep). The four wheezing-focused ISAAC-WM
items capture and quantify these observable manifestations of wheezing illness. If we assume
that wheezing illness (the latent construct) is driving observed correlations among the ISAAC-
WM wheezing items, then their shared variance can be used to estimate wheezing illness as a
continuous latent variable. Modeling associations with well-specified latent variables generally
results in increased statistical power [22,27].
We evaluated our proposed model of wheezing illness severity in three independent
cohorts. Two of these cohorts are part of the Children’s Respiratory Research and Environ-
ment Workgroup (CREW) within the ECHO initiative [21], and the third is a publicly avail-
able data set from the ISAAC Phase I study [6]. Nearly all ECHO airway cohorts have used the
ISAAC-WM, thus a more powerful approach to estimating severity in explanatory research
studies with this instrument may be of broad interest. We address whether the proposed latent
factor model of pediatric wheezing severity is:
1. consistent with observed data in all three cohorts
2. positively and concurrently associated with established markers of wheezing illness (con-
vergent validity)
3. stable over repeated time points (longitudinal invariance) and across child sexes
4. positively and prospectively associated with wheeze-related clinical outcomes (predictive
validity)
A valid latent variable approach to measuring wheezing severity with the ISAAC-WM may
facilitate stronger tests of etiological theory and advancements in our understanding of pediat-
ric wheezing illness.
Materials and methods
Data sources and measures
Table 1 provides demographic characteristics for each cohort.
Cohort 1. INSPIRE birth cohort study. The Infant Susceptibility to Pulmonary Infec-
tions and Asthma following RSV Exposure (INSPIRE) study is an ongoing population-based
birth cohort that is part of the ECHO/CREW consortium, evaluating the role of early life
A latent variable model of pediatric wheezing severity
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respiratory infection in pediatric asthma [19,28]. The study enrolled term and otherwise
healthy infants (N = 1,951) in Middle Tennessee. The Vanderbilt University Institutional
Review Board (IRB) approved all study procedures. Wheezing symptoms are assessed annually
using the parent-reported ISAAC-WM [19]. Although all participants complete the ISAAC-
WM, given our focus on wheezing severity, we included only children whose parents reported
wheezing in the first two years of life (n = 657).
At both the one- and two-year assessments, parents reported whether or not their children
used asthma medications and/or had been hospitalized for respiratory illnesses in the prior
year. With regard to asthma medications, parents were asked explicitly if their children had
been treated with any of the following: Budesonide, Fluticasone, Beclomethasone, Montelu-
kast, Albuterol, Budesonide-Salmeterol, Fluticasone-Salmeterol, Prednisone/Prednisolone,
Dexamethasone, or any other asthma medications. At the year-three assessment, parents
reported several wheeze-related clinical outcomes: physician diagnosis of asthma at any point
in life (Absent or Present), past-year treatment of asthma symptoms with any form of cortico-
steroid (Never, 1–3 times, 4+ times), and past-year frequency of wheeze-related healthcare visits
(None, 1–3, 4+). When asking parents about corticosteroid use, no distinction was made
between parenteral steroids or oral corticosteroids in the questioning.
Cohort 2. ISAAC Phase 1 study. Cohort 2 analyses used publicly available data from the
ISAAC Study Phase I (http://isaac.auckland.ac.nz/phases/phaseone/results/resultsIndv.php) to
Table 1. Participant characteristics for all cohorts.
n Proportion
Cohort 1: INSPIRE (n = 657)
Maternal History of Asthma 154 0.23
Child RSV+ Molecular Diagnostic Test 66 0.10
Maternal Prenatal Cigarette Smoking (Any) 139 0.21
Medicaid Insurance at Enrollment 377 0.57
Child Cesarean Birth Delivery 224 0.34
Child Sex: Female 250 0.38
Mother Married at Enrollment 368 0.56
Child Race
African American 167 0.25
Asian 10 0.02
Native American/Native Alaskan 6 0.01
Native Hawaiian/Pacific Islander 2 0.003
White 510 0.78
Other Race 37 0.06
Child Ethnicity: Hispanic/Latino 58 0.09
Cohort 2: ISAAC Phase 1 (n = 2,765)
Child Sex: Female 1,193 0.43
Cohort 3: EHAAS (n = 102)
Child Sex: Female 34 0.33
Child Race/Ethnicity




Other Race 1 0.01
https://doi.org/10.1371/journal.pone.0194739.t001
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evaluate whether the covariance patterns implied by the latent wheezing severity model estab-
lished in Cohort 1 were consistent with observed covariance patterns in an independent dataset.
Detailed study procedures are available in prior publications [3,5]. ISAAC Phase I included two
cohorts of children (ages 6–7 and ages 13–14) from 38 countries. We limited analyses to 6-7-year-
old children from the three North American countries: Canada, U.S.A., and Barbados. This was
felt to be most representative of the ECHO/CREW consortium sites. Analyses included the subset
of children who, by parent report, had ever had wheezing episodes (n = 2,765).
Cohort 3. EHAAS birth cohort. Cohort 3 analyses evaluated whether the latent wheezing
severity model established with Cohort 1 was consistent with observed data patterns in the
Epidemiology of Home Allergens and Asthma Study (EHAAS) study, and whether the latent
factor was prospectively associated with wheezing morbidity. EHAAS is a prospective birth
cohort study that is also part of the ECHO/CREW consortium (N = 505) [20,29–31]. Families
from a Boston hospital were eligible if the biological mother was 18+ years old at enrollment,
at least one biological parent had a history of allergies or asthma, infants were born term with-
out major congenital anomalies and were not admitted to the neonatal intensive care unit.
Study procedures were approved by the Brigham and Women’s Hospital IRB. We evaluated
ISAAC-WM data collected when children were 5 and 6 years old. Analyses were limited to the
subsample of children whose parents reported wheezing episodes at some point during the
two-year follow-up window (n = 102). Clinical outcomes at age 7 included whether or not the
child had: (1) a physician diagnosis of asthma, (2) any prior-year wheezing-related medical vis-
its, and (3) any prior-year wheezing-related urgent visits to a healthcare provider’s office or
emergency department.
Statistical analyses
Structural equation modeling (SEM) was the primary analytic strategy with parameters esti-
mated via robust weighted least squares [32]. Fig 1A shows the hypothesized latent wheezing
severity model. Associations between the latent wheezing severity variable and the ordinal
ISAAC-WM severity items were estimated using a latent response variable framework
[22,32,33], in which ordered categorical outcomes (y1, y2, y3, y4) are conceptualized as coarse




). The models used probit
regressions to estimate c-1 thresholds (τ) for ordinal outcomes, where c is the number of
ordered levels, dividing the underlying continuous distributions into discrete categories [32].
Analyses were conducted using the lavaan package version 0.5–22 [34] in R [35] and Mplus
version 7.4 [36]. Missing data in the response variables were presumed to be missing at ran-
dom conditional on the model covariates [37].
The ISAAC Phase 1 data (Cohort 2) had a complex structure with children nested within
schools (j = 282) within study sites (k = 3). We used multilevel SEM [38,39] to evaluate the
latent wheezing severity factor model while accounting for clustering (dependence) within
schools (Fig 1B). On the within-school level, the wheezing severity model was identical to the
model specified in Cohort 1. On the between-schools level, we specified a saturated model
where all indicator variances and covariances were freely estimated and the indicators were
regressed on dummy variables coding study site. This approach accounts for between-school
and between-site variability, but presumes that wheezing severity is a meaningful construct
only on the within-schools level of analysis; that is, wheezing severity is only intended to be
measured as a child-level characteristic, not a school-level characteristic [40].
In the Cohort 3 analyses, to avoid sparse cells for the ISAAC-WM indicators, data for each
of the ISAAC-WM items were aggregated across the age-5 and age-6 assessments (Table 2).
These aggregated items were used in all models.
A latent variable model of pediatric wheezing severity
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Assessing model adequacy. In all three cohorts, the degree of discrepancy between pro-
posed models and observed data was assessed using a mean- and variance-adjusted χ2 Good-
ness of Fit (χ2GOF) test [32,37,41,42]. Significant χ
2
GOF values lead to a rejection of the null
hypothesis of a perfect correspondence between the model and the observed data [22]. We
reported two additional indices of model adequacy: the root mean error of approximation
(RMSEA) [43,44] and comparative fit index (CFI) [45]. The RMSEA provides an estimate of
the amount of misspecification per model degree of freedom with a 90% confidence interval
(CI), whereas the CFI compares the hypothesized model to a simpler baseline (null) model,
penalizing the hypothesized model for each estimated parameter [46]. Although there are no
perfect cutoff values for these indices [47], RMSEA values< .05 and CFI values .95 are gen-
erally considered to be indicative of a desirable model [48].
It is noteworthy that, owing to the relatively small sample size, Study 3 models were under-
powered to detect significant model misspecification with the χ2GOF test. Consequently, we
relied on data from studies 1 and 2 to assess whether our proposed latent wheezing severity
model was consistent with the observed data, whereas Study 3 analyses were focused on evalu-
ating whether the latent wheezing severity variable was prospectively associated with estab-
lished markers of wheezing illness severity (predictive validity).
Convergent validity. Using Cohort 1 data at both the year-one and year-two assessments,
we specified models evaluating concurrent associations between the latent wheezing severity
factor and parent-reported markers of wheezing illness: wheezing medication use (Any vs.
None) and respiratory hospitalizations (Any vs. None). These associations were adjusted for
seven potential confounders representing characteristics that have been linked to asthma risk
in prior studies [49]: maternal asthma history [50] (Absent vs. Present), maternal prenatal ciga-
rette use [51] (None vs. Any), maternal marital status [52] (Married vs. Single), insurance at
Fig 1. Latent variable model of wheezing illness severity. Panel a shows the latent wheezing severity model used in
cohorts 1 and 3. The severity of wheezing illness is estimated as a unidimensional latent variable (η1) with four
reflective ordinal indicators: wheezing episode frequency (y1), frequency of wheeze-related sleep disturbance (y2),
wheeze-related speech disturbance (y3), and exercise-induced wheeze (y4). The ordinal indicators are presumed to be
coarse measurements of underlying continuous variables (y1
-y4
). Panel b shows the multilevel wheezing severity
model used in the Cohort 2 analyses. The within-schools level of the model is identical to panel a. The between-schools
level of the model accounts for non-independence due to clustering within schools and study sites. Estimated
parameters are depicted in red.
https://doi.org/10.1371/journal.pone.0194739.g001
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enrollment as a proxy for socioeconomic status [53] (Private vs. Medicaid), birth method [54]
(Vaginal vs. Cesarean), child sex [55], and child race [55] (African American, all other race
groups, and white race [reference group]). Both the markers of wheezing illness severity (valid-
ity outcomes) and the latent wheezing factor were regressed on these seven asthma risk
factors.
Latent factor stability. Using Cohort 1 data, we evaluated whether our latent wheezing
severity model was stable across the one- and two-year follow-ups using procedures described
in Liu et al. (2016) [56]. An unstable factor structure indicates that the latent construct cannot
be measured reliably in the same way across repeated assessments, making it challenging to
interpret change over time [56–58]. Four competing models, representing differing degrees of
instability, were specified and compared using scaled χ2 likelihood ratio tests [59]. Significant
χ2 tests are not desirable in this context because they indicate that models allowing for instabil-
ity in the factor structure fit better than more restrictive models that assume stability. The
most desirable model allows mean levels of wheezing severity (the latent factor) to change over
Table 2. Cohort 3 EHAAS study: Derived wheezing severity items characterizing the severity of wheeze across the
60- and 72-month assessments combined.
ISAAC-WM WHEEZING ITEM DERIVED SEVERITY LEVELS COMBINING ACROSS
THE 60- AND 72-MONTH ASSESSSMENTS
Item 3. Number of wheezing attacks in past 12 months Very infrequent (value = 0)
• None (60-Month) and 1–3 attacks (72-Month)
• 1–3 attacks (60-Month) and None (72-Month)
Infrequent (value = 1)
• 1–3 attacks (60-Month) and 1–3 attacks (72-Month)
• None (60-Month) and 4–12 attacks (72-Month)
• 4–12 attacks (60-Month) and None (72-Month)
Frequent (value = 2)
• 1–3 attacks (60-Month) and 4–12 attacks (72-Month)
• 4–12 attacks (60-Month) and 1–3 attacks (72-Month)
• None (60-Month) and 13+ attacks (72-Month)
• 13+ attacks (60-Month) and None (72-Month)
Very frequent (value = 3)
• 4–12 attacks (60-Month) and 4–12 attacks
(72-Month)
• 4–12 attacks (60-Month) and 13+ attacks (72-Month)
• 13+ attacks (60-Month) and 4–12 attacks (72-Month)
• 13+ attacks (60-Month) and 13+ attacks (72-Month)
Item 4. Child’s sleep disturbed due to wheezing Never (value = 0)
• Never (60-Month) and Never (72-Month)
Infrequent (value = 1)
• Never (60-Month) and < 1 night/week (72-Month)
• < 1 night/week (60-Month) and Never (72-Month)
Frequent (value = 2)
• Never (60-Month) and 1+ nights/week (72-Month)
• 1+ nights/week (60-Month) and Never (72-Month)
• <1 night/week (60-Month) and <1 night/week
(72-Month)
• <1 night/week (60-Month) and 1+ nights/week
(72-Month)
• 1+ nights/week (60-Month) and <1 night/week
(72-Month)
• 1+ nights/week (60-Month) and 1+ nights/week
(72-Month)
Item 5. Wheezing ever severe enough to child’s speech
to only one or two words at a time between breaths
Absent at both assessments (value = 0)
Present at either or both assessments (value = 1)
Item 7. Wheezing or whistling in chest during or after
exercise
Absent at both assessments (value = 0)
Present at either or both assessments (value = 1)
https://doi.org/10.1371/journal.pone.0194739.t002
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time, but holds the measurement of wheezing severity (factor loadings, thresholds, and resid-
ual variances) constant over time. In all models, the latent wheezing factor was regressed on
the seven asthma risk factors described above, with associations between risk factors and the
latent factor permitted to vary freely across time points. We used similar procedures [60] to
test whether the latent factor measurement was consistent across sexes (female vs. male chil-
dren) [61].
Predictive validity. Using Cohort 1 data, we specified longitudinal models evaluating
whether the latent wheezing illness factor at the two-year assessment was prospectively associ-
ated with year-three clinical outcomes, including physician asthma diagnosis, acute corticoste-
roid use, and wheeze-related outpatient visits. These prospective associations were adjusted for
all seven asthma risk factors described above. Using Cohort 3 data, we evaluated whether the
latent wheezing severity variable measured at ages 5–6 was prospectively associated with
wheeze-related outcomes at age 7, adjusting for child sex and race.
Comparison to discrete severity models. Using data from Cohort 1, we gauged whether
the latent factor approach to estimating wheezing severity as a continuous construct had
greater predictive utility relative to a more traditional approach with a discrete severity vari-
able. To accomplish this, we first derived a five-level ordinal wheezing severity variable indicat-
ing the number of ISAAC-WM wheezing items endorsed (i.e., present to some degree) at the
year-two assessment (None, 1, 2, 3, 4). We then reran the latent variable predictive validity
models described in the prior section, using the same covariates and estimation procedures,
but replacing the latent wheezing severity factor with the ordinal severity variable. This allowed
us to evaluate whether the latent variable modeling approach yielded stronger associations
with the future clinical outcomes (physician asthma diagnosis, acute corticosteroid use, and
wheeze-related outpatient visits) compared to the more traditional discrete severity approach.
Results
Table 3 provides descriptive statistics for the ISAAC-WM severity items for all three cohorts.
Separate online appendixes for Cohort 1 (S1 Appendix), Cohort 2 (S2 Appendix), and Cohort
3 (S3 Appendix) are available providing model code. For cohorts 1 and 3, we provide sufficient
summary statistics (covariance matrixes, weighted least squares weight vector, asymptotic vari-
ance matrix, and sample size) to allow others to reproduce our models (S1 File).
Model fit
Table 4 provides information about model adequacy for all models. Model numbers are pro-
vided in the table and are referenced in the text below.
Cohort 1. INSPIRE birth cohort. The unidimensional latent factor model of wheezing ill-
ness severity (Fig 1A) provided a close fit to the observed data at both the one- and two-year
assessments, as indicated by non-significant χ2GOF tests (Table 4, models 1.1 and 1.2). At both
assessments, there were strong positive associations between the latent wheezing factor and
the ISAAC-WM wheezing indicators (S1 Fig). Consistent with prior research using a different
instrument [16], information curves showed that levels of wheezing illness severity factor
could be estimated with greatest precision at moderate to high levels of illness severity: The
latent factor was less informative for children with mild wheezing symptoms (S2 Fig).
Cohort 2. ISAAC Phase 1. Consistent with Cohort 1 findings, the multilevel SEM model
evaluating the wheezing severity as a unidimensional construct yielded a non-significant
χ2GOF test (Table 4, Model 2.1), indicating a close fit to the data. Associations between the
latent factor and all four indicators were positive and significant on the within-school level of
analysis.
A latent variable model of pediatric wheezing severity
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Cohort 3. EHAAS birth cohort. Consistent with findings from cohorts 1 and 2, the hypoth-
esized unidimensional factor model yielded a non-significant w2GOF test (Table 4, Model 3.1). Thus,
there was no evidence of model misspecification. This finding should be interpreted cautiously,
Table 3. Descriptive statistics for ISAAC-wheezing module severity items.
LEVELS COUNT PROP COUNT PROP
Cohort 1: INSPIRE 1st Year of Life 2nd Year of Life
# of Wheeze Episodes Never 205 0.31 156 0.24
1 to 3 328 0.50 274 0.42
4 to 12 73 0.11 76 0.12
13+ 28 0.04 17 0.03
Missing 23 0.04 134 0.20
Wheeze Disturbs Sleep Never 455 0.69 336 0.51
< 1 night/week 83 0.13 93 0.14
1+ nights/week 96 0.15 94 0.14
Missing 23 0.04 134 0.20
Wheeze Disturbs Speech Present 116 0.18 100 0.15
Missing 24 0.04 135 0.21
Exercise-Induced Wheeze Present 67 0.10 76 0.12
Missing 14 0.02 33 0.05
Cohort 2: ISAAC Phase 1
# of Wheeze Episodes Never 1,173 0.42
1 to 3 1,074 0.39
4 to 12 330 0.12
13+ 107 0.04
Missing 81 0.03
Wheeze Disturbs Sleep Never 1,793 0.65
< 1 night/week 641 0.23
1+ nights/week 228 0.08
Missing 103 0.04
Wheeze Disturbs Speech Present 259 0.09
Missing 91 0.03
Exercise-Induced Wheeze Present 714 0.26
Missing 119 0.04
Cohort 3: EHAAS
# of Wheeze Episodes Very Infrequent 31 0.30
Infrequent 39 0.38
Frequent 12 0.12
Very frequent 16 0.16
Missing 4 0.04




Wheeze Disturbs Speech Present 11 0.11
Missing 3 0.03
Exercise-Induced Wheeze Present 28 0.27
Missing 1 0.01
PROP = proportion of the total sample.
https://doi.org/10.1371/journal.pone.0194739.t003
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however, as the model was underpowered to detect a significant discrepancy between the model
and data because of the relatively small sample size in the Cohort 3 analyses.
Convergent validity
Using Cohort 1 data at both the one- and two-year assessments, the wheezing illness factor
was positively associated with hospitalization for respiratory illness (Table 5, models 1.3 and
Table 4. Indices of model adequacy.
χ2GOF RMSEA CFI Model Description
Cohort 1: INSPIRE Birth Cohort
Est df p Est 90% CI Est
Model 1.1 2.35 2 .31 .02 .00, .08 1.0 Y1: Wheeze severity model
Model 1.2 3.76 2 .15 .04 .00, .10 1.0 Y2: Wheeze severity model
Model 1.3 27.19 29 .56 .00 .00, .03 1.0 Y1: Concurrent association with respiratory hospital visit
Model 1.4 31.08 29 .36 .01 .00, .03 .97 Y2: Concurrent association with respiratory hospital visit
Model 1.5 26.75 29 .59 .00 .00, .03 1.0 Y1: Concurrent association with asthma medication
Model 1.6 29.47 29 .44 .01 .00, .03 1.0 Y2: Concurrent association with asthma medication
Model 1.7 29.48 29 .44 .01 .00, .03 .99 Prospective associations with Y3 asthma diagnosis
Model 1.8 29.28 29 .45 .00 .00, .03 1.0 Prospective associations with Y3 corticosteroids
Model 1.9 29.01 29 .46 .00 .00, .03 1.0 Prospective associations with Y3 wheeze medical visits
Cohort 2: ISAAC Phase 1
Model 2.1 0.48 2 .79 .02 NA 1.0 Wheeze severity model
Model 2.2 7.20 5 .21 .00 NA 1.0 Regression of wheeze severity factor on child sex
Cohort 3: EHAAS Birth Cohort
Model 3.1 0.83 2 .66 .00 .00, .15 1.0 Wheeze severity model
Model 3.2 4.00 8 .86 .00 .00, .06 1.0 Regression of wheeze severity on child sex and race
Model 3.3 7.01 11 .80 .00 .00, .07 1.0 Predictive validity: 84-month asthma dx.
Model 3.4 7.22 11 .78 .00 .00, .07 1.0 Predictive validity: 84-month wheeze visits
Model 3.5 6.05 11 .87 .00 .00, .05 1.0 Predictive validity: 84-month ER visits
w2GOF = model chi-square goodness of fit test; RMSEA = root mean error of approximation; CFI = Comparative Fit Index; Y1-Y3 = Year 1 –Year 3; NA = RMSEA
confidence intervals were not available for multilevel SEM models.
https://doi.org/10.1371/journal.pone.0194739.t004
Table 5. Cohort 1: Associations between the latent wheezing illness severity factors at both year-1 and year-2 and established markers of wheezing illness severity.
LATENT FACTOR MODEL EST 95% CI
Marker of Wheezing Illness Severity # βa Lower Upper
Year 1 Wheezing Illness Severity (Ages 0–1)
Ages 0–1Wheeze -Related Hospitalizations 1.3 0.68 0.51 0.86
Ages 0–1 Asthma Medication Use 1.5 0.87 0.72 1.01
Year 2 Wheezing Illness Severity (Ages 1–2)
Ages 1–2Wheeze -Related Hospitalizations 1.4 0.54 0.35 0.72
Ages 1–2 Asthma Medication Use 1.6 0.90 0.77 1.03
Ages 2–3 Asthma Diagnosis 1.7 0.71 0.53 0.88
Ages 2–3 Acute Corticosteroid Use 1.8 0.63 0.49 0.76
Ages 2–3Wheeze-Related Medical Visits 1.9 0.64 0.48 0.79
aLinear regression coefficient estimating the association between the latent wheezing illness severity factor and the continuous latent variable (y) underlying the
observed categorical outcome variable (y) that is an established marker of wheezing severity.
https://doi.org/10.1371/journal.pone.0194739.t005
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1.4) and asthma medication use (Table 5, models 1.5 and 1.6) adjusting for covariates. Fig 2
shows the magnitude of these concurrent associations at year-one.
Latent factor stability
Using Cohort 1 data, there was no evidence from likelihood ratio χ2 tests (p values .20) that
imposing invariance restrictions on the loadings, thresholds, or unique variances across time
points worsened model fit (Table 6). Thus, there was no evidence of temporal instability,
allowing for meaningful evaluation of change in the latent factor. Additionally, there was no
evidence of latent factor instability across child sex at either year-one or year-two (p values
.25; Table 6), indicating that the same latent wheezing severity model was reasonable for girls
and boys
Consistent with prior research [62], male children scored higher on average than female
children on the wheezing illness severity factor in all three cohorts. In Cohort 1 analyses, male
children scored 0.20 (95% CI [0.02, 0.45]) standard deviations (SDs) higher (more severe
Fig 2. Cohort 1: Concurrent associations between the latent wheezing severity factor and markers of wheezing illness in year-one. This
figure shows estimated probabilities of having at least one respiratory hospitalization (panel a; model 1.3) and using asthma medication (panel b;
model 1.5) against levels of the latent wheezing severity variable in the first year of life. As wheezing severity increases so does the estimated
probability of respiratory hospitalization and medication use. These models held all covariates constant at their median values. Dotted lines
represent 95% confidence intervals for estimated probability estimates.
https://doi.org/10.1371/journal.pone.0194739.g002
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symptoms) than females on the latent factor in the second year of life. Similarly, in cohorts 2
(model 2.2) and 3 (model 3.2), male children scored 0.09 SDs (95% CI [0.003, 0.18]) and 0.68
SDs (95% CI [0.01, 1.35]) higher on wheezing severity than females, respectively.
Predictive validity
In Cohort 1 longitudinal models, the severity of wheezing illness in the second year of life was
uniquely and prospectively associated with year-three physician asthma diagnosis (model 1.7),
acute corticosteroid use (model 1.8), and wheeze-related outpatient visits (model 1.9), adjust-
ing for covariates (Table 5). Using Cohort 3 data, adjusting for covariates, the latent wheezing
illness factor representing wheezing severity measured at ages 5–6 was prospectively associated
with all clinical outcomes measured at age 7 (Fig 3): physician asthma diagnosis (model 3.3; β
= 0.52, 95% CI [0.22, 0.82]), wheeze -related medical visits (model 3.4; β = 0.58, 95% CI [0.20,
0.96]), and urgent wheeze-related medical visits (model 3.5; β = 0.82, 95% CI [0.41, 1.24]).
Comparison with discrete wheezing severity model
Using Cohort 1 data, the discrete wheezing severity variable coding the number of
ISAAC-WM severity items endorsed at the year-two assessment was significantly and posi-
tively associated with year-three asthma diagnosis, acute corticosteroid use, and wheeze/
asthma-related outpatient visits. Thus, the discrete severity exposure variable had utility in pre-
dicting future wheezing morbidity. However, Fig 4 illustrates the potential benefits of model-
ing wheezing severity as a latent continuous variable in explanatory models. Fig 4A plots the
estimated probability of a child having at least one wheeze-related medical visit in the third
year of life against the year-2 discrete wheezing severity variable, adjusting for covariates. As
the number of ISAAC-WM severity items endorsed increased in the second year of life (x-
Table 6. Cohort 1: Comparison of models testing stability in the latent wheezing severity factor across time and across child sex.
Measurement Parameters χ2GOF Model Comparison
Factor Loadings Indicator
Thresholds
Residual Variances Est. df p Models χ2DIFF p
Models Evaluating Measurement Stability Across One- and Two-Year Assessments
1 Free Free Free 61.97 62 .48 - - -
2 Constant Free Free 64.52 65 .49 2 vs 1 0.22 .97
3 Constant Constant Free 68.19 68 .47 3 vs 2 4.10 .20
4 Constant Constant Constant 69.58 72 .56 4 vs 3 0.92 .88
Models Evaluating Measurement Stability Across Child Sex (Female vs. Male) at Year-One
5 Free Free Free 46.31 46 .46 - - -
6 Constant Free Free 49.64 49 .45 6 vs 5 2.97 .25
7 Constant Constant Free 51.45 51 .46 7 vs 6 0.63 .60
8 Constant Constant Constant 52.69 55 .56 8 vs 7 0.68 .85
Models Evaluating Measurement Stability Across Child Sex (Female vs. Male) at Year-Two
9 Free Free Free 38.95 46 .76 - - -
10 Constant Free Free 41.01 49 .78 10 vs 9 0.72 .72
11 Constant Constant Free 42.95 51 .78 11 vs 10 1.24 .37
12 Constant Constant Constant 47.83 55 .74 12 vs 11 2.70 .37
w2GOF = chi-square goodness of fit statistic evaluating whether the model is consistent with the observed data; w
2
DIFF = chi-square test comparing the fit of competing
nested models; Free = parameter was allowed to vary freely across groups (i.e., time points or child sex); Constant = parameter was constrained to be equal across groups
(i.e., time points or child sex).
https://doi.org/10.1371/journal.pone.0194739.t006
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axis) the estimated probability of a child having a wheeze-related medical visit in the third year
of life (y-axis) increased. In the discrete severity model, however, there are only five possible
values of the estimated probability of year-three wheeze-related medical visits, ranging from
0.05 to 0.63, corresponding to the five levels of the discrete severity variable.
In contrast, Fig 4B shows the estimated probabilities of year-3 wheeze-related medical visits
as a function of the latent wheezing severity factor, with estimated probabilities following a
smooth curve ranging from 0.01 (at -3 SDs) to 0.82 (at +3 SDs). Going from the lowest level of
the discrete wheezing severity variable to the highest results in a 0.59 (95% CI [0.34, 0.83])
increase in the estimated probability of year-3 wheeze-related medical visits; whereas going
from 3 SDs below the mean to 3 SDs above the mean on the latent severity variable results in
an increase in the estimated probability of 0.81, 95% CI [0.67, 0.94]. Similar patterns were
observed for year-3 physician asthma diagnosis (Fig 5) and acute corticosteroid treatment (Fig
6). Also, the degree of uncertainty around the estimated probabilities was smaller when using
the latent wheezing severity model. This is consistent with our central premise that a latent
Fig 3. Cohort 3: Prospective associations between wheezing illness severity and wheeze-related morbidity outcomes. In the EHAAS birth
cohort study, there were strong prospective associations between the latent wheezing illness severity factor representing wheezing illness severity
from 60–72 months and three asthma morbidity outcomes at the 84-month follow-up: physician diagnosis of asthma (panel a; model 3.3), any
asthma medical visits (panel b; model 3.4), and urgent asthma/wheeze-related medical visits to either a doctor’s office or the emergency department
(panel c; model 3.5). These models held all covariates constant at their median values. Dotted lines represent 95% confidence intervals. Pseudo-R2
values represent the approximate proportion of variance in the outcome accounted for by the predictors.
https://doi.org/10.1371/journal.pone.0194739.g003
A latent variable model of pediatric wheezing severity
PLOS ONE | https://doi.org/10.1371/journal.pone.0194739 April 17, 2018 13 / 22
severity model can provide improved estimation of severity, resulting in stronger associations
with clinical outcomes.
Discussion
Summary of key findings
The findings from three independent studies support the utility of a unidimensional latent var-
iable approach to measuring pediatric wheezing illness severity based on items from the
ISAAC-WM in explanatory research studies. We found:
1. a close correspondence between the latent wheezing severity model and the observed data
(cohorts 1 and 2);
Fig 4. Cohort 1: Estimated probability of year-three wheeze-related medical visits as a function of wheezing severity in year-2. These plots
show the strength of associations between year-2 wheezing severity (x-axis) and year-3 wheeze-related medical visits (y-axis), with all covariates
held constant at their median values. Panels a shows estimated probabilities of corticosteroid treatment being present in the third year of life as a
function of the discrete severity exposure variable; whereas panel b shows estimated probabilities vs. the latent continuous severity factor. In both
models, as year-2 wheezing severity increases, so does the estimated probability of acute corticosteroid treatment, though the range of estimated
probabilities is larger in the latent severity model. Values and 95% confidence intervals above the blue brackets show the increase in the estimated
probabilities for a given increase in wheezing severity. Dotted lines represent 95% confidence intervals for estimated probability estimates.
https://doi.org/10.1371/journal.pone.0194739.g004
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2. concurrent (Cohort 1) and prospective (cohorts 1 and 3) associations with wheeze-related
clinical outcomes;
3. stability in the latent wheezing severity factor structure across time points and child sex
(Cohort 1);
4. stronger prospective associations with wheezing outcomes compared to a discrete severity
variable (Cohort 1).
Interpretation and implications
Wheezing is the hallmark of asthma and an indicator of asthma control [63,64]. The ISAAC
questionnaire is a validated instrument used in epidemiologic studies worldwide [3,4]. The use
Fig 5. Cohort 1: Year-3 physician asthma diagnosis as a function of wheezing severity in year-2. These plots show the strength of associations
between year-2 wheezing severity (x-axis) and year-3 physician asthma diagnosis (y-axis), with all covariates held constant at their median values.
Panels a shows estimated probabilities of a physician asthma diagnosis being present in the third year of life as a function of the discrete severity
exposure variable; whereas panel b shows estimated probabilities vs. the latent continuous severity factor. In both models, as year-2 wheezing
severity increases, so does the estimated probability of a physician asthma diagnosis being present, though the range of estimated probabilities is
larger in the latent severity model. Values and 95% confidence intervals above the blue brackets show the expected increase in the estimated
probabilities for a given increase in wheezing severity. Dotted lines represent 95% confidence intervals for estimated probability estimates.
https://doi.org/10.1371/journal.pone.0194739.g005
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of wheezing questions to assess disease severity in etiological research is highly desirable, par-
ticularly for the new ECHO consortium in which nearly all of the asthma birth cohorts utilized
the ISAAC-WM. Our latent variable approach yields a continuous measure of wheezing illness
severity that capitalizes on shared variance from the four wheezing-focused ISAAC-WM
items. Our findings suggest that this latent variable approach results in stronger associations
with established measures of wheezing illness severity than models using discrete severity vari-
ables based on the ISAAC-WM. Thus, for studies using the ISAAC-WM, the proposed latent
variable approach may result in stronger tests of etiological theory than models using discrete
severity variables.
It is important to note that the proposed SEM-based latent variable approach is intended
for use in explanatory research models, where the goal is to test specific etiological hypotheses
and theories. Latent variables do not yield unique scores for individual respondents [65].
Fig 6. Cohort 1: Year-3 estimated probability of acute corticosteroid treatment as a function of wheezing severity in year-2. These plots
show the strength of associations between year-2 wheezing severity (x-axis) and year-3 acute corticosteroid treatment (y-axis), with all covariates
held constant at their median values. Panels a shows estimated probabilities of corticosteroid treatment being present in the third year of life as a
function of the discrete severity exposure variable; whereas panel b shows estimated probabilities vs. the latent continuous severity factor. In both
models, as year-2 wheezing severity increases, so does the estimated probability of acute corticosteroid treatment, though the range of estimated
probabilities is larger in the latent severity model. Values and 95% confidence intervals above the blue brackets show the increase in the estimated
probabilities for a given increase in wheezing severity. Dotted lines represent 95% confidence intervals for estimated probability estimates.
https://doi.org/10.1371/journal.pone.0194739.g006
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Consequently, our proposed SEM-based latent variable model of wheezing severity could not
be used in clinical practice to aid in diagnostic decisions or to make patient-specific predic-
tions about risk for future adverse outcomes [65]. There are, however, a number of existing
questionnaires measuring wheezing severity that were designed and validated for these pur-
poses [18]. However, for researchers testing specific etiological models of wheezing illness
development and/or outcomes with the ISAAC-WM, this approach could lead to stronger
tests of theory. We provided programming code for both lavaan (open-source) and Mplus
(proprietary) in online appendices to facilitate implementation in datasets utilizing the
ISAAC-WM.
Despite its widespread use, this was the first study, to our knowledge, to test a model of
wheezing illness severity using the ISAAC-WM. Our model was founded in the hypothesis
that wheezing severity can be conceptualized as a continuous unidimensional latent variable
and that the categorical ISAAC-WM items are surrogates, capturing measurable consequences
of this unobserved variable. In each cohort, the χ2GOF test, which is highly sensitive to model
misspecifications with large sample sizes [66,67], found no significant evidence of discrepan-
cies between the covariance matrixes implied by our proposed model of wheezing severity and
the observed covariance matrixes.
This was also the first study to explicitly evaluate whether a model of pediatric wheezing
severity was consistent over time (longitudinal invariance) and across child sexes. Our Cohort
1 analyses suggested that the factor structure (i.e., the relationship between the latent factor
and its measured indicators) was stable over the first two years of life, allowing for meaningful
evaluation of change in pediatric wheezing severity. Although males and females differed in
their mean levels of wheezing severity, there was no evidence that the latent factor structure
was inconsistent across child sexes. This means that a single model of wheezing severity in
early childhood for girls and boys may be sufficient as long as analyses account for mean differ-
ences across sexes.
Finally, we demonstrated the benefits of using a continuous latent factor model within a
structural equation modeling framework compared to a discrete wheezing severity variable in
terms of its power to detect associations with future clinical outcomes. Going from the lowest
to highest levels of the latent factor was associated with a greater increase in the estimated
probability of future wheezing morbidity outcomes compared to going from the lowest to
highest levels of a discrete severity variable. Thus, the latent factor approach may yield more
powerful tests of etiological associations than categorical severity variables.
While there are a number of strengths of this study, including evaluation of the latent vari-
able approach in three independent datasets, there are several limitations which should be con-
sidered. First, we relied exclusively on parent report for the measurement of both wheezing
symptoms and validity outcomes; though the ISAAC-WM was designed and validated for this
purpose. Second, we tested our factor model using just four ordinal indicators. More precise
measurements of the indicators (e.g., exact counts of wheezing episodes) should result in better
severity estimation. Greater precision might also be achieved by combining the ISAAC-WM
items with other indicators of wheezing severity, assuming that they are theoretically and
empirically commensurate with the proposed model. Third, our models were unidimensional
and only captured variability in wheezing symptoms. Prior studies suggest that asthma is a
multidimensional construct [16–18], with wheezing severity represented in one of the dimen-
sions. Future studies should explore whether the proposed latent wheezing severity model can
be combined with other symptom dimensions to provide a more comprehensive representa-
tion of asthma severity [68,69]. Fourth, the latent factor model does not discriminate as well
among children who are low on the severity spectrum compared to those with moderate to
severe symptoms. Adding indicators that better distinguish between children with mild
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symptoms would be desirable in future studies. Lastly, it is important to note that SEM gener-
ally requires large samples and may not be feasible in smaller studies [70].
Conclusions
In conclusion, the proposed latent variable model of pediatric wheezing illness estimates
wheezing severity as a continuous construct, is consistent with data from three independent
cohorts, and is prospectively associated with asthma morbidity. This modeling approach can
be applied in cohorts with ISAAC-WM data with a sufficient sample size by adapting the pro-
vided code. Using a latent severity approach provides more powerful testing of etiological
hypotheses.
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